Professor Alistair McGuire

Professor Alistair McGuire

Head of Department, Professor of Health Economics

Department of Health Policy

020 7955 6375
Room No
COW 2.02
Office Hours
Wednesday 16.00-17.00
Connect with me

Key Expertise
cost-effectiveness analysis, economic evaluation

About me

Professor Alistair McGuire is Head of Department and Chair of Health Economics at the Department of Health Policy. Prior to this he was Professor of Economics at City University, London after being a tutor in Economics at the University of Oxford. Professor McGuire has also been a Visiting Professor at Harvard University, the University of Sydney, the University of York, and the Universitat Pompeu Fabra, Barcelona.

He has acted as an advisor to a number of governments and governmental bodies, including the United Kingdom government, the UK Competition Commission, the UK Medical Research Council (MRC), the German Institut fur Qualität Wirtschaftlichkeit im Gesundheitswesen (IQWiG), as well as for a number of international bodies (including the World Bank, the WHO, and the IMF) and pharmaceutical and health care insurance companies. 

Professor McGuire has pursued an interest in the economics of health care for over thirty years. His research cover all topics in health economics, including international comparisons, economics of the hospital, public/private sector interface, cost-effectiveness analysis of health technologies, and health economics alongside clinical trials. He also has extensive teaching experience and has written numerous books, articles and reports on this. He has been involved in a number of major clinical trials as the lead health economist.


Expertise Details

comparative effectiveness research; cost-effectiveness analysis; economic evaluation; pharmaeconomics; health economics; health services research

My research

Ovarian cancer symptoms, routes to diagnosis and survival – population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)


Author(s) James Dilley, Matthew Burnell, Aleksandra Gentry-Maharaj, Andy Ryan, Christina Neophytou, Sophia Apostolidou, Chloe Karpinskyj, Jatinderpal Kalsi, Tim Mould, Robert Woolas, Naveena Singh, Martin Widschwendter, Lesley Fallowfield, Stuart Campbell, Steven J. Skates, Alistair McGuire, Mahesh Parmar, Ian Jacobs, Usha Menon

A 2 x 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over…


Author(s) Judy Martina Bradley, Rohan Anand, Brenda O'Neill, Kathryn Ferguson, Mike Clarke, Mary Carroll, James Chalmers, Anthony De Soyza, Jamie Duckers, Adam T. Hill, Michael R. Loebinger, Fiona Copeland, Evie Gardner, Christina Campbell, Ashley Agus, Alistair McGuire, Roisin Boyle, Fionnuala McKinney, Naomi Dickson, Danny F. McAuley, Stuart Elborn